Zealand Pharma A/S (ZEAL): Price and Financial Metrics

Zealand Pharma A/S (ZEAL)

Today's Latest Price: $30.67 USD

1.05 (-3.31%)

Updated Apr 3 12:00am

Add ZEAL to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 214 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

ZEAL Stock Summary

  • Of note is the ratio of Zealand Pharma A's sales and general administrative expense to its total operating expenses; just 0.23% of US stocks have a lower such ratio.
  • For ZEAL, its debt to operating expenses ratio is greater than that reported by merely 0.34% of US equities we're observing.
  • With a year-over-year growth in debt of -100%, Zealand Pharma A's debt growth rate surpasses just 0% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Zealand Pharma A are LGND, HMG, GPOR, PHX, and CHAP.
  • Visit ZEAL's SEC page to see the company's official filings. To visit the company's web site, go to www.zealandpharma.com.
ZEAL Daily Price Range
ZEAL 52-Week Price Range

ZEAL Stock Price Chart More Charts

ZEAL Price/Volume Stats

Current price $30.67 52-week high $44.60
Prev. close $31.72 52-week low $18.07
Day low $30.00 Volume 2,900
Day high $31.03 Avg. volume 10,935
50-day MA $34.63 Dividend yield N/A
200-day MA $28.75 Market Cap 1.11B

Zealand Pharma A/S (ZEAL) Company Bio

Zealand Pharma A/S, a biotech company, engages in the discovery, design, and development of novel peptide-based medicines in Denmark. The company was founded in 1997 and is based in Copenhagen, Denmark.

ZEAL Latest News Stream

Event/TimeNews Detail
Loading, please wait...

ZEAL Latest Social Stream

Loading social stream, please wait...

View Full ZEAL Social Stream

ZEAL Price Returns

1-mo -18.93%
3-mo -6.92%
6-mo 30.73%
1-year 60.04%
3-year N/A
5-year N/A
YTD -7.62%
2019 185.96%
2018 -14.63%
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7119 seconds.